Literature DB >> 12100489

Molecular regulation of melanocyte senescence.

Dorothy C Bennett1, Estela E Medrano.   

Abstract

Cell senescence is the loss of ability to divide after a finite number of divisions, seen in normal mammalian somatic cells and often disrupted in cancer cells. The three genes so far associated with familial melanoma susceptibility--INK4A, CDK4 and ARF, are all implicated in the molecular pathways controlling cell senescence. Here we review those pathways, both as generally studied in fibroblasts and epithelial cells, and as specifically analysed in melanocytes. Key molecular effectors in melanocyte senescence appear to include some in common with other cell types - telomere attrition and the p16/RB pathway, and one that is not commonly mentioned in this connection, the cAMP signalling pathway that also regulates melanocyte differentiation. These findings are discussed in relation to the role of cell senescence in the development and molecular genetics of melanoma and its precursor lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100489     DOI: 10.1034/j.1600-0749.2002.02036.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  17 in total

Review 1.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 2.  Functional role of cellular senescence in biliary injury.

Authors:  Luke Meng; Morgan Quezada; Phillip Levine; Yuyan Han; Kelly McDaniel; Tianhao Zhou; Emily Lin; Shannon Glaser; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2015-01-22       Impact factor: 4.307

Review 3.  Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.

Authors:  Elisabeth I Minder; Jasmin Barman-Aksoezen; Xiaoye Schneider-Yin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

4.  PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.

Authors:  Maja Grabacka; Wojciech Placha; Krystyna Urbanska; Piotr Laidler; Przemysław M Płonka; Krzysztof Reiss
Journal:  Pigment Cell Melanoma Res       Date:  2008-04-26       Impact factor: 4.693

Review 5.  The role of cell differentiation in controlling cell multiplication and cancer.

Authors:  Karl-Hartmut von Wangenheim; Hans-Peter Peterson
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-15       Impact factor: 4.553

Review 6.  Melanomagenesis: overcoming the barrier of melanocyte senescence.

Authors:  Linan Ha; Glenn Merlino; Elena V Sviderskaya
Journal:  Cell Cycle       Date:  2008-04-23       Impact factor: 4.534

7.  Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.

Authors:  Leon Raskin; Douglas R Fullen; Thomas J Giordano; Dafydd G Thomas; Marcus L Frohm; Kelly B Cha; Jaeil Ahn; Bhramar Mukherjee; Timothy M Johnson; Stephen B Gruber
Journal:  J Invest Dermatol       Date:  2013-04-30       Impact factor: 8.551

8.  The chemotherapeutic agents XK469 (2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid) and SH80 (2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid) inhibit cytokinesis and promote polyploidy and induce senescence.

Authors:  John J Reiners; Miriam Kleinman; Aby Joiakim; Patricia A Mathieu
Journal:  J Pharmacol Exp Ther       Date:  2008-12-09       Impact factor: 4.030

9.  Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression.

Authors:  Julia K Soo; Alastair D Mackenzie Ross; David M Kallenberg; Carla Milagre; W Heung Chong; Jade Chow; Lucy Hill; Stacey Hoare; Rebecca S Collinson; Mehnaz Hossain; W Nicol Keith; Richard Marais; Dorothy C Bennett
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-20       Impact factor: 4.693

10.  Nevus senescence.

Authors:  Andrew L Ross; Margaret I Sanchez; James M Grichnik
Journal:  ISRN Dermatol       Date:  2011-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.